United States
US 12,702,640 B2
Drug implants containing enzalutamide and methods of use thereof
US 12,702,640 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-11. Applicant: Alessa Therapeutics, Inc.; The Regents of the University of California. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- Alessa Therapeutics, Inc.; The Regents of the University of California
- Inventors
- Maithili Rairkar; Pujan Desai; Carlos Schuler; Keith Hall; Pamela Munster; John Maroney; Scott Thomas
- Publication date
- 2026-08-11
- Filing date
- 2023-04-25
- Document type
- B2 Granted patent
- Also written as
- US 12,702,640 B2 · US12702640 · 12702640
Abstract
Provided herein are drug implants comprising enzalutamide for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and enzalutamide disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may be used for the treatment of a proliferative disease of the prostate.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free